Pritumumab
Pritumumab Basic information
- Product Name:
- Pritumumab
- Synonyms:
-
- pritumumab
- Research Grade Pritumumab(DHC35301)
- Research Grade Pritumumab
- CAS:
- 499212-74-7
- MW:
- 0
- Mol File:
- Mol File
Pritumumab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
Pritumumab Usage And Synthesis
Uses
Pritumumab is a natural human IgG1kappa mAb originally isolated from a regional draining lymph node of a patient with cervical carcinoma. Pritumumab recognizes vimentin expressing on the cell surface of the malignant tumor. Pritumumab can be used for glioblastoma research[1][2].
in vivo
Pritumumab is effective in preventing tumor growth in nude mice but not in SCID mice[1].
Pritumumab can limit the growth of xenograft glioma tumors in vivo only in the presence of intact cell-mediated immunity[1].
References
[1] Santosh Kesari, et al. Pritumumab binding to glioma cells induces ADCC and inhibits tumor growth. ASCO Annual Meeting I. 2017.
[2] Hugwil AV. The meaning of the anti-cancer antibody CLN-IgG (Pritumumab) generated by human × human hybridoma technology against the cyto-skeletal protein, vimentin, in the course of the treatment of malignancy. Med Hypotheses. 2013 Sep;81(3):489-95. DOI:10.1016/j.mehy.2013.05.037
PritumumabSupplier
- Tel
- 010-56205725
- waley188@sohu.com
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
- Tel
- 15817493340
- 981810490@qq.com
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
- Tel
- 4008200310
- marketing@tsbiochem.com